Qualitative or quantitative defects of titin

Qualitative or quantitative defects of titin refer to a group of rare genetic disorders caused by mutations in the TTN gene, which encodes titin — the largest known human protein. Titin is a giant sarcomeric protein that plays a critical role in the structural integrity and elasticity of striated muscle, spanning from the Z-disc to the M-line of the sarcomere in both skeletal and cardiac muscle. Defects in titin can lead to a wide spectrum of neuromuscular and cardiac diseases, depending on the nature and location of the mutation within this enormous gene. Clinical manifestations of titin-related disorders primarily affect the skeletal muscular system and the heart. Skeletal muscle involvement can range from early-onset myopathies with severe weakness and hypotonia to later-onset limb-girdle muscular dystrophies and distal myopathies (such as tibial muscular dystrophy or Udd myopathy). Cardiac involvement frequently manifests as dilated cardiomyopathy, which can occur in isolation or alongside skeletal muscle disease. Some patients may also develop restrictive cardiomyopathy or hypertrophic cardiomyopathy. The severity and age of onset are highly variable, influenced by the specific mutation, its location within the titin protein, and the inheritance pattern. There is currently no curative treatment for titin-related disorders. Management is supportive and multidisciplinary, including physical therapy and rehabilitation for skeletal muscle weakness, cardiac monitoring and standard heart failure therapies (such as ACE inhibitors, beta-blockers, and diuretics) for cardiomyopathy, respiratory support when needed, and orthopedic interventions for contractures or scoliosis. Genetic counseling is recommended for affected families. Research into gene therapy and other targeted approaches is ongoing but remains in early stages.

Common questions about Qualitative or quantitative defects of titin